Bird Flu Research Reconsidered

Biosecurity agency will give controversial H5N1 bird flu research another look-over in light of new data and clarification.

Written byHannah Waters
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Transmission electron micrograph of H5N1 virions.WIKIMEDIA COMMONS, CENTERS FOR DISEASE CONTROL

Yesterday (February 29) at a short-notice meeting held by the American Society of Microbiologists, the National Institute of Allergy and Infectious Diseases head Anthony Fauci announced that government agencies will ask the National Science Advisory Board for Biosecurity (NSABB) to reconsider publication of controversial H5N1 research.

These “two most famous unpublished manuscripts in modern science history,” as infectious disease researcher and NSABB panel member Michael Osterholm described them to MedScape, contain details of how to engineer the H5N1 virus to become more transmissible in ferrets, raising concerns of a bioterrorism threat. After the NSABB recommended that parts of the papers be redacted, furious debate has stirred among government officials, scientists, and even the World Health Organization (WHO) over whether the research should be published.

At ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies